Adventa Berhad is an investment holding company. The Company, through its subsidiaries, manufactures and distributes sterile surgical and medical examination gloves as well as distributes medical and hospital related products. Adventa also generates and supplies energy and electricity using biomass technology.
Genaral Info: ADVENTA 7191
Number of Share
152, 785, 770
Market Capital (RM)
152, 021, 841
Forecasted Profit or Loss (RM)
-3, 244, 039
Estimated Future EPS (sen)
-2.123
Perspective P/E ratio
-46.862
Estimated Dividend Yield (%)
2.167
Adjusted NTA (RM)
0.343
Result
Quarter Report History
Date
Revenue,k
PBT,k
Net Profit,k
26/02/21
12,706
-9,984
-9,285
25/11/20
14,466
-5,227
-5,227
26/08/20
46,373
1,579
1,691
21/05/20
13,674
908
1,008
27/02/20
11,642
-6,057
-6,457
26/11/19
9,522
29,432
30,211
29/08/19
9,249
364
-384
30/05/19
8,486
-435
-1,229
28/02/19
7,773
-27,056
-27,427
26/12/18
9,589
-608
-569
28/09/18
13,420
1,373
757
20/06/18
15,360
1,316
702
Fundamental
Fundamental Analysis
Last 4 Quarter Revenue (RM’000)
87,219
Last 4 Quarter Net Profit (RM’000)
-12,325
Last 4 Quarter EPS (sen)
-7.69
Last 4 Quarter PER
–
Last 4 Quarter Dividend (sen)
–
Last 4 Quarter Dividend Yield (%)
–
Net Tangible Assets (RM)
0.36
Goodwill (RM)
3,620
Cash (RM’000)
12,310
Debt (RM’000)
2,690
Total Debt (RM’000)
27,720
Net Assets (RM’000)
64,500
Current Ratio
2.44
Quick Ratio
2.09
Cash Ratio
1.21
Technical
Technical Analysis
MACD (26 vs 12)
-0.086
Exponential Moving Average 5
0.799
Exponential Moving Average 20
0.865
Exponential Moving Average 90
1.319
Relative Strength Index 14
0.28
Stochastic %D 3
0.20
Stochastic %K 14
0.35
4 reviews for ADVENTA 7191
2.4out of 5
★★★★★
★★★★★
0
★★★★★
0
★★★★★
4
★★★★★
2
★★★★★
1
Write a review
Show allMost HelpfulHighest RatingLowest Rating
BURSA MALAYSIA –
Revenue for 2Q 2020 was RM 46.37 million, a 337% increase compared to RM 1Q 2020 at RM 13.7m. The increase in revenue was contributed by the sales of PPE and other medical consumables linked to the Covid-19 pandemic and the effect of the movement controls.
Helpful(0)Unhelpful(0)You have already voted this
★★★★★
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 1.24 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8 million and auditor’s remuneration of 135 thousands
Helpful(0)Unhelpful(0)You have already voted this
BURSA MALAYSIA –
Revenue for 1Q 2020 was RM 13.67 million, an increase of 17% compared to RM 11.64 million in 4Q 2019. The increase in revenue was mainly contributed by the sales of PPE amid Covid-19 pandemic. Profit before tax and EBITDA reported improvement in current quarter were mainly due to better profit margin from the sales of PPE; Deferred development cost of home dialysis products was written off; Impairment of trade receivables.
Helpful(0)Unhelpful(0)You have already voted this
★★★★★
Investing Malaysia –
Average investing volume for Adventa Bhd in the past three months in stock market was 245.1k lots
Helpful(0)Unhelpful(0)You have already voted this
★★★★★
Investing Malaysia –
ADVENTA gets a score of 9.87 in our equity and assets quality test based on current share price of RM0.645
Helpful(0)Unhelpful(0)You have already voted this
★★★★★
Investing Malaysia –
Adventa Bhd gets a score of 16.8 in our stability test after the balance sheet, money statement study
Helpful(0)Unhelpful(0)You have already voted this
★★★★★
Investing Malaysia –
Stock code of 7191 in Bursa Malaysia did not propose any dividend for the past few years
Helpful(0)Unhelpful(0)You have already voted this
★★★★★
Investing Malaysia –
ADVENTA is forecasted to made loss of 0.83 millions, with an adjusted market capitalization of 96.26 millions
Helpful(0)Unhelpful(0)You have already voted this
★★★★★
REMUNERATION STUDY –
In Financial Year End 2018, the directors’ remuneration was 1.64 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8.4 million and auditor’s remuneration of 155 thousands
BURSA MALAYSIA –
Revenue for 2Q 2020 was RM 46.37 million, a 337% increase compared to RM 1Q 2020 at RM 13.7m. The increase in revenue was contributed by the sales of PPE and other medical consumables linked to the Covid-19 pandemic and the effect of the movement controls.
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 1.24 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8 million and auditor’s remuneration of 135 thousands
BURSA MALAYSIA –
Revenue for 1Q 2020 was RM 13.67 million, an increase of 17% compared to RM 11.64 million in 4Q 2019. The increase in revenue was mainly contributed by the sales of PPE amid Covid-19 pandemic. Profit before tax and EBITDA reported improvement in current quarter were mainly due to better profit margin from the sales of PPE; Deferred development cost of home dialysis products was written off; Impairment of trade receivables.
Investing Malaysia –
Average investing volume for Adventa Bhd in the past three months in stock market was 245.1k lots
Investing Malaysia –
ADVENTA gets a score of 9.87 in our equity and assets quality test based on current share price of RM0.645
Investing Malaysia –
Adventa Bhd gets a score of 16.8 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 7191 in Bursa Malaysia did not propose any dividend for the past few years
Investing Malaysia –
ADVENTA is forecasted to made loss of 0.83 millions, with an adjusted market capitalization of 96.26 millions
REMUNERATION STUDY –
In Financial Year End 2018, the directors’ remuneration was 1.64 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8.4 million and auditor’s remuneration of 155 thousands